Finance

Lists
NERV:NASDAQ
Minerva Neurosciences, Inc
$2.38
+1.27%
(+0.030) 1D
Oct 19, 1:52:31 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NERV...
Open
$2.37
High
$2.47
Low
$2.28
Mkt. cap
113.63M
Avg. vol.
151.03K
Volume
27.18K
52-wk high
$12.46
52-wk low
$2.28
EPS
-$28.46
Beta
-0.75
Shares outstanding
47.75M
No. of employees
7
Open
$2.37
High
$2.47
Low
$2.28
Mkt. cap
113.63M
Avg. vol.
151.03K
Volume
27.18K
52-wk high
$12.46
52-wk low
$2.28
EPS
-$28.46
Beta
-0.75
Shares outstanding
47.75M
No. of employees
7
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
34 minutes ago
Magnificent Seven Are Losing Their Earnings Luster
About Minerva Neurosciences, Inc
CEO-
Employees7
Founded2007
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to NERV in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NERV in the last 3 months.
Highest
Current $2.38
$10.00 (+320.20%)
Average
$8.50 (+257.17%)
Lowest
$7.00 (+194.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Tsai
Jefferies
Buy
Upgraded
$10.00
+320.2%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
$7.00
+194.1%
08/10/2026
Jason Butler
Citizens JMP
Buy
Initiated
$14.00
+488.3%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
5.25M
-
Cost of revenue
-
-
5.25M
-
Research and development expenses
925.38K
2.17M
-
7.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.92M
2.81M
11.42M
3.45M
Operating expense
2.84M
4.98M
11.42M
10.64M
Total operating expenses
2.84M
4.98M
16.67M
10.64M
Operating income
-2.84M
-4.98M
-16.67M
-10.64M
Other non operating income
-
-279.21M
-109.36M
27.55M
EBT including unusual items
-2.74M
-283.67M
-125.40M
17.47M
EBT excluding unusual items
-2.74M
-283.67M
-125.40M
17.47M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.74M
-283.67M
-125.40M
17.47M
Net profit margin
-
-
-
-
Earnings per share
-
-0.64
-0.17
-0.17
Interest and investment income
106.64K
546.52K
629.60K
569.59K
Interest expense
-
-
-
-
Net interest expenses
106.64K
546.52K
629.60K
569.59K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.84M
-4.98M
-16.67M
-10.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps